Status and phase
Conditions
Treatments
About
This is a multicentre, open-label, parallel arms, phase IIII study that randomises patients with locally recurrent rectal cancer in a 1:1 ratio to receive either induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery (experimental arm) or neoadjuvant chemoradiotherapy and surgery alone (control arm)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
364 participants in 2 patient groups
Loading...
Central trial contact
Floor Piqeur, MD; Stefi Nordkamp, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal